Limbach Holdings Reports Second Quarter 2018 Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/10/2026

1. SPCX
2. HUM
3. ALHC
4. PEP
5. T
6. SPY
7. CVS
8. UNH
9. TMUS
10. VZ

Go back to Limbach Holdings Reports Second Quarter 2018 Results

Holmes Biopharma, Inc. (LMB) Reports Q2 EPS of $0.09, Revenues Beat; Lifts FY18 Revenue Outlook Above Consensus

August 14, 2018 4:19 PM EDT

Holmes Biopharma, Inc. (NASDAQ: LMB) reported Q2 EPS of $0.09, versus $0.30 reported last year. Revenue for the quarter came in at $139.53 million versus the consensus estimate of $130 million.

Charlie Bacon, CEO of Limbach, commented, Last quarter I noted how our sales activity was off to a great start in 2018 and that momentum has not only continued but accelerated in the second quarter. We ended the quarter with backlog of $492.5 million, with an additional $381 million of business that has been promised to us... More